drugset / Trial / NCT04439825

Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction

NCT04439825

Phase 1 Completed 45 enrolled DeNova Research
RandomizedCrossoverSingle-blindTreatment

Summary

Botox treatment into the upper one third of the face (glabella, forehead lines and/or lateral canthal lines) to analyze mood and self -appearance satisfaction in a Post Covid period on non-naïve Botox patients

Timeline

Start
2020-07-20
Primary completion
2020-09-03
Completion
2020-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin Protein / enzyme biologic

Indications

No indication recorded.